Page last updated: 2024-11-07

2-propanoyl-3-(4-tolyl)tropane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-propanoyl-3-(4-tolyl)tropane: structure given in first source (toluyl in SY#3 used incorrectly by author) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID127862
SCHEMBL ID20942835
MeSH IDM0232063

Synonyms (11)

Synonym
1-(8-methyl-3-(4-methylphenyl)-8-azabicyclo(3.2.1)oct-2-yl)-1-propanone (1r-(exo,exo))-
152783-29-4
2-propanoyl-3-(4-tolyl)tropane
2-ptt
2-propanoyl-3-(4-toluyl)tropane
1-propanone, 1-(8-methyl-3-(4-methylphenyl)-8-azabicyclo(3.2.1)oct-2-yl)-, (1r-(exo,exo))-
2beta-propanoyl-3beta-(4-tolyl)-tropane
SCHEMBL20942835
rel-(+)-1-[(1r,2s,3s,5s)-8-methyl-3-(4-methylphenyl)-8-azabicyclo[3.2.1]oct-2-yl]-1-propanone
DTXSID60934599
1-[(1r,2s,3s,5s)-8-methyl-3-(4-methylphenyl)-8-azabicyclo[3.2.1]octan-2-yl]propan-1-one

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Groups of rats were trained to self-administer cocaine, heroin, or cocaine/heroin combinations using a within session dosing procedure in which three doses were available each session."( Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats.
Davies, HM; Martin, TJ; Sizemore, GM; Smith, JE, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (58.33)18.2507
2000's5 (41.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.62 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]